Prosecution Insights
Last updated: November 20, 2026
Application No. 17/927,309

SYSTEMS AND METHODS FOR DETECTING THE PRESENCE OF ELECTRICALLY EVOKED COMPOUND ACTION POTENTIALS (eCAPS), ESTIMATING SURVIVAL OF AUDITORY NERVE FIBERS, AND DETERMINING EFFECTS OF ADVANCED AGE ON THE ELECTRODE-NEURON INTERFACE IN COCHLEAR IMPLANT USERS

Non-Final OA §101§112
Filed
Nov 22, 2022
Priority
May 22, 2020 — provisional 63/028,677 +3 more
Examiner
MONTGOMERY, MELISSA JO
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Ohio State University
OA Round
3 (Non-Final)
15%
Grant Probability
At Risk
3-4
OA Rounds
0m
Est. Remaining
55%
With Interview

Examiner Intelligence

Grants only 15% of cases
15%
Career Allowance Rate
4 granted / 27 resolved
-55.2% vs TC avg
Strong +40% interview lift
Without
With
+40.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
37 currently pending
Career history
88
Total Applications
across all art units

Statute-Specific Performance

§101
24.4%
-15.6% vs TC avg
§103
30.2%
-9.8% vs TC avg
§102
18.3%
-21.7% vs TC avg
§112
26.5%
-13.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 27 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 25 JUNE 2026 has been entered. Response to Amendment The amendments filed 25 JUNE 2026 have been entered. Claims 1, 3 – 7, 9, 11 – 15, 17, and 19 - 23 are pending. Applicant’s amendments to the claims have overcome each and every objection to the claims previously applied in the office action dated 05 FEBRUARY 2026. Applicant’s amendments have overcome each and every rejection applied under 35 U.S.C. 112 in the office action dated 05 FEBRUARY 2026. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. As claimed, the “second time period” is intended to be “before the first time period”. It is not clear where those time periods are relative to the steps depicted between Figs. 6B and 6H (in particular Figs 6D and 6H). It is requested to clarify the potential locations of these time periods with an annotated drawing depicting labeled exemplar “first” and “second” time periods. Therefore, the first and second time periods must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. The drawings are further objected to because The black and white keys for the drawings to differentiate between the waveforms are not apparent to tell the difference (as an example, dashed lines vs solid), and are not presented in color. An example, Fig. 6H appears to have the “Template” and the Neural Response” both as dotted lines with squares over them. The differences between the lines cannot be ascertained. As such, the differences in the figures that are intended to be communicated per the keys are not adequately communicated. Looking to Fig. 6E, the N1 part of the waveforms is between 200 µs and 400 µs on the horizontal scale. For Fig. 6F, the title is “Method example: Scale template horizontally to match peak time values”, and the N1 values of the waveform are now aligned between the -200 µs and 0 µs. It is unclear if this negative alignment is intentional, and it the negative timing means before the measurement took place. Then for Fig. 6H for “Trim waveforms to overlapping time period”, the portion of the waveforms where N1 appeared to be in Figs. 6F and 6G is aligned close to 300 µs. It is unclear why the waveforms are translating along the horizontal axis, and why the start of the horizontal axis is changing with each figure. This change in axis does not appear consistent with the described signal analysis steps. Per the title of Figure 6G, it is intended to show the “Trim waveforms to overlapping time period”. However, it is unclear if there is a portion of the waveform being trimmed in Fig. 6G, which portion of the waveform is trimmed, and what constitutes “overlapping”. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. Claim Objections Claims 1, 9, and 17 are objected to because of the following informalities: regarding the term “trimming any portions of the re-sampled neural response waveform and the scaled template eCAP waveform”. It is suggested to remove the “any” for consistency and readability of the claim with the rest of the subsequently-recited “portions of the re-sampled neural response waveform and the scaled template eCAP waveform.” Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention Claims 1, 3 – 7, 9, 11 – 15, 17, and 19 - 23 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 (line 22), Claim 9 (line 27), and Claim 17 (line 23) each recite the term “the second overlapping time period”. There is insufficient antecedent basis for this limitation in the claim. It is unclear if this is the same or different than the previously-recited second time period. It is also unclear if this is intended to be a time period where there are wavelengths present that overlap, or if this is a time period whose time window overlaps on the time axis with another window of time. For the purposes of examination, the term “the second overlapping time period” is deemed to claim “the second time period”. Claims 3 – 7, 11 – 15, and 19 - 23 are similarly rejected due to their dependence on Claims 1, 9, and 17. Claim 1 (lines 24 - 28), Claim 9 (lines 29 - 33), and Claim 17 (lines 25 – 29) each recite the term “wherein the second time period occurs before the first time period to use the portions of the scaled re-sampled neural response waveform and the scaled template eCAP waveform occurring during the second time period in a correlation analysis”. It is unclear if the signal portions that are being resampled are in a time period section before any portion that has undergone any of the remaining processing steps. Looking to the drawings, Fig. 6D indicates a step of “subtract off mean value in first 600 µs from template and neural response waveforms”. Looking to Claims 1, 9, and 17, that appears to be illustrating a ”subtracting, in a first time period, the first mean voltage from the template eCAP waveform and the second mean voltage from the re-sampled neural response waveform”. As such, it appears that the first time period could be 0 – 600 µs. It is unclear how a second time period could thus occur before 0 µs. Then in Fig. 6H, “Resample with higher resolution before 600 µs”. Looking to Claims 1, 9, and 17, that appears to be illustrating “re-sampling both the re-sampled neural response waveform and the scaled template eCAP waveform at the second overlapping time period with a second sampling rate having a higher resolution than the first sampling rate used to re-sample the neural response waveform, wherein second time period occurs before the first time period to use the portions of the re-sampled neural response waveform and the scaled template eCAP waveform occurring during the second time period in a correlation analysis”. For this figure the “second time period” appears to also be 0 – 600 µs. It is generally unclear if the waveforms that are being used in the correlation analysis are intended to be associated with the normalized waveforms previously-recited in the claim, or if the first time period and second time period are being used for separate analyses of the template and neural response waveforms, such that analyses in the second time period bypass any normalization of the signal performed for the first time period data. Looking to Claim 5, it is interpreted that the “wherein the first time period comprises between 0 and 600 µs of the template eCAP waveform and the re-sampled neural response waveform” is referring to a duration, where, for example, a 300 µs section of the waveform that starts at 500 µs could be extracted and called the “first time period”. However, if the claimed intent is that the first time period is 0 – 600 µs, then that is consistent with the lack of clarity in the figures of a first time period of 0 – 600 µs having a second time period before it. The metes and bounds of the time periods of Claims 1, 9, and 17 cannot be ascertained, and clarification or revision is requested. Claims 3 – 7, 11 – 15, and 19 - 23 are similarly rejected due to their dependence on Claims 1, 9, and 17. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. Regarding Claim 1, the claim recites "an act or step, or series of acts or steps" and is therefore a process, which is a statutory category of invention (Step 1). The claim is then analyzed to determine whether it is directed to any judicial exception (Step 2A, Prong 1). Regarding Claims 9 and 17 the claims each recite an apparatus, which is one of the statutory categories of invention (Step 1). The claim is then analyzed to determine whether it is directed to any judicial exception (Step 2A, Prong 1). Each of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 has been analyzed to determine whether it is directed to any judicial exceptions. Step 2A, Prong 1 Each of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 recites at least one step or instruction for observations, evaluations, judgments, and opinions, which are grouped as a mental process under the 2019 PEG. The claimed invention involves making observations, evaluations, judgments, and opinions, which are concepts performed in the human mind under the 2019 PEG. Accordingly, each of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 recites an abstract idea. Specifically, Independent Claims 1, 9, and 17 recite (underlined are observations, judgements, evaluations, or opinions, which are grouped as a mental process under the 2019 PEG) (additional elements bolded, see Step 2A, prong 2); Unique to Claim A method of determining whether an electrically evoked compound action potential (eCAP) exists in a neural response comprising: providing a template eCAP waveform; Unique to Claim 9 A system for determining whether an electrically evoked compound action potential (eCAP) exists in a neural response comprising: a memory; and a processor in communication with the memory, wherein the processor executes computer-executable instructions stored in the memory, said instructions causing the processor to: retrieve a template eCAP waveform from the memory; Unique to Claim 17 A non-transitory computer readable medium comprising computer-executable instructions stored on the non-transitory computer readable medium, said computer-executable instructions for performing a method of determining whether an electrically evoked compound action potential (eCAP) exists in a neural response, said method comprising: receiving a template eCAP waveform; For Claims 1, 9, and 17: receiving a recorded neural response waveform obtained from a patient with a cochlear implant; re-sampling the recorded neural response waveform with a first sampling rate; normalizing the re-sampled neural response waveform and the template eCAP waveform by determining a first mean voltage of the template eCAP waveform and a second mean voltage of the re- sampled neural response waveform and subtracting, in a first time period, the first mean voltage from the template eCAP waveform and the re-sampled neural response waveform, respectively; determining a first negative (N1) peak and a trailing positive peak (P2) in each of the re- sampled neural response waveform and the template eCAP waveform; scaling the template eCAP waveform in a vertical voltage axis to match an amplitude of the first negative (N1) peak and an amplitude of the trailing positive peak (P2) from the re-sampled neural response waveform and scaling the template eCAP waveform in a horizontal time axis to match latencies in each the re-sampled neural response waveform N1 and the re-sampled neural response waveform P2; trimming any portions of the re-sampled neural response waveform and the scaled template eCAP waveform to a second time period where both waveforms overlap; re-sampling both the re-sampled neural response waveform and the scaled template eCAP waveform at the second overlapping time period with a second sampling rate having a higher resolution than the first sampling rate used to re-sample the neural response waveform, wherein the second time period occurs before the first time period to use the portions of the re-sampled neural response waveform and the scaled template eCAP waveform occurring during the second time period in a correlation analysis; calculating the correlation analysis between the re-sampled re-sampled neural response waveform and the re-sampled scaled template eCAP waveform; and determining whether the correlation analysis between the re-sampled re-sampled neural response waveform and the re-sampled scaled template eCAP waveform indicates that the neural response waveform comprises the eCAP; and if the neural response waveform comprises the eCAP, then the eCAP determines an estimated number of surviving neurons in a cochlear nerve of the patient, and the cochlear implant of the patient is adjusted using the estimated number of surviving neurons in the cochlear nerve. (observation, judgment or evaluation, which is grouped as a mental process under the 2019 PEG); Examiner notes that adjusting the cochlear implant would not be considered a mental process, with the interpretation that the adjustment is at automatic adjustment of Applicant’s Specification at [0044] of “deactivating electrodes of the cochlear implant near nerves that do not function properly and/or passing more stimulation/information through regions with the best functioning nerves. D. Repeat a – c for each electrode in the cochlear implant; resulting in e. Optimized setting of the cochlear implant that help the patient hear better”. However, given the adjustment limitation under the conditionality of “if”, the claim does not necessarily require any adjustment of the cochlear implant and can just require the remaining abstract elements, which would be a mental process. These underlined limitations describe a mathematical calculation and/or a mental process, as a skilled practitioner is capable of performing the recited limitations and making a mental assessment thereafter. Examiner notes that nothing from the claims suggests that the limitations cannot be practically performed by a human with the aid of a pen and paper, or by using a generic computer as a tool to perform mathematical calculations and/or mental process steps in real time. Examiner additionally notes that nothing from the claims suggests and undue level of complexity that the mathematical calculations and/or the mental process steps cannot be practically performed by a human with the aid of a pen and paper, or using a generic computer as a tool to perform mathematical calculations and/or mental process steps. For example, in Independent Claims 1, 9, and 17, these limitations include: Evaluating by re-sampling the recorded neural response waveform with a first sampling rate; Evaluating by normalizing the re-sampled neural response waveform and the template eCAP waveform by determining a first mean voltage of the template eCAP waveform and a second mean voltage of the re- sampled neural response waveform and subtracting, in a first time period, the first mean voltage from the template eCAP waveform and the re-sampled neural response waveform, respectively; Observation and judgment to determine a first negative (N1) peak and a trailing positive peak (P2) in each of the re- sampled neural response waveform and the template eCAP waveform; Observation and judgment to scale the template eCAP waveform in a vertical voltage axis to match an amplitude of the first negative (N1) peak and an amplitude of the trailing positive peak (P2) from the re-sampled neural response waveform Observation and judgment to scale the template eCAP waveform in a horizontal time axis to match latencies in each the re-sampled neural response waveform N1 and the re-sampled neural response waveform P2 Observation and judgement to trim any portions of the re-sampled neural response waveform and the scaled template eCAP waveform to a second time period where both waveforms overlap Evaluating by re-sampling both the re-sampled neural response waveform and the scaled template eCAP waveform at the second overlapping time period with a second sampling rate having a higher resolution than the first sampling rate used to re-sample the neural response waveform, wherein the second time period occurs before the first time period to use the portions of the re-sampled neural response waveform and the scaled template eCAP waveform occurring during the second time period in a correlation analysis; Evaluating the correlation analysis between the re-sampled re-sampled neural response waveform and the re-sampled scaled template eCAP waveform; Observation and judgment whether the correlation analysis between the re-sampled re-sampled neural response waveform and the re-sampled scaled template eCAP waveform indicates that the neural response waveform comprises the eCAP; if the neural response waveform comprises the eCAP, then the eCAP is the basis of an observation and judgment of an estimated number of surviving neurons in a cochlear nerve of the patient Similarly, Dependent Claims 3 – 7, 11 – 15, and 19 – 23 include the following abstract limitations, in addition the aforementioned limitations in Independent Claims 1, 9 and 17 (underlined observation, judgment or evaluation, which is grouped as a mental process under the 2019 PEG): up-sampling the neural response waveform via cubic spline interpolation to create a smooth re-sampled neural response waveform at a higher sampling rate than is used to obtain the neural response waveform. Evaluating by up-sampling the neural response waveform via cubic spline interpolation to create a smooth re-sampled neural response waveform at a higher sampling rate than is used to obtain the neural response waveform. re-sampling both waveforms with the second sampling rate occurring between 0 and 600 µ-sec Evaluating by re-sampling both waveforms with the second sampling rate occurring between 0 and 600 µ-sec calculating a Pearson correlation between the re-sampled scaled re-sampled neural response waveform and the re-sampled template eCAP waveform. Evaluating a Pearson correlation between the re-sampled scaled re-sampled neural response waveform and the re-sampled template eCAP waveform. all of which are grouped as mental processes or mathematical algorithms under the 2019 PEG. Accordingly, as indicated above, each of the above-identified claims recite an abstract idea. Step 2A, Prong 2 The above-identified abstract ideas in each of Independent Claims 1, 9 and 17 (and their respective Dependent Claims) are not integrated into a practical application under 2019 PEG because the additional elements (identified in Claims 1 - 20), either alone or in combination, generally link the use of the above-identified abstract ideas to a particular technological environment or field of use. More specifically, the additional elements of: “cochlear implant” “memory” “processor” “non-transitory computer readable medium” Additional elements recited include a “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” in Independent Claims 1, 9 and 17 (and their respective Dependent Claims). These components are recited at a high level of generality, , i.e., as a processor performing a generic function of processing data (the receiving, sampling, calculating for example); and a memory and non-transitory medium performing a generic function of storing data (the storing). These generic hardware component limitations for “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” are no more than mere instructions to apply the exception using generic computer and hardware components. As such, these additional elements do not impose any meaningful limits on practicing the abstract idea. Further additional elements from Independent Claims 1, 9, and 17 include pre-solution activity limitations, such as: providing a template eCAP waveform; receive a neural response waveform obtained from a patient with a cochlear implant; a processor in communication with the memory, wherein the processor executes computer-executable instructions stored in the memory, said instructions causing the processor to: retrieve a template eCAP waveform from the memory; In addition the aforementioned extra-solution activity limitations in Independent Claim 25, additional extra-solution activity limitations recited in Dependent Claims 3 – 7, 11 – 15, and 19 - 23 include: the first time period comprises between 0 and 600 µ-sec of the template eCAP waveform and the re-sampled neural response waveform. wherein the neural response waveform is obtained by sending a user-defined stimuli through one electrode of the cochlear implant to stimulate surrounding neurons and recording an electrical response of the surrounding electrons using a neighboring electrode in the cochlear implant. These pre-solution measurement elements are insignificant extra-solution activity, setting up the parameters of the system, and serve as data-gathering for the subsequent steps. The “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” as recited in Independent Claims 1, 9 and 17 (and their respective Dependent Claims) are generically recited computer and hardware elements which do not improve the functioning of a computer, or any other technology or technical field. Nor do these above-identified additional elements serve to apply the above-identified abstract idea with, or by use of, a particular machine, effect a transformation or apply or use the above-identified abstract idea in some other meaningful way beyond generally linking the use thereof to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception. Furthermore, the above-identified additional elements do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer. For at least these reasons, the abstract ideas identified above in Independent Claims 1, 9 and 17 (and their respective Dependent Claims) is not integrated into a practical application under 2019 PEG. Moreover, the above-identified abstract idea is not integrated into a practical application under 2019 PEG because the claimed method and system merely implements the above-identified abstract idea (e.g., mental process and certain method of organizing human activity) using rules (e.g., computer instructions) executed by a computer processor as claimed. In other words, these claims are merely directed to an abstract idea with additional generic computer elements which do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer. Additionally, Applicant’s specification does not include any discussion of how the claimed invention provides a technical improvement realized by these claims over the prior art or any explanation of a technical problem having an unconventional technical solution that is expressed in these claims. That is, like Affinity Labs of Tex. v. DirecTV, LLC, the specification fails to provide sufficient details regarding the manner in which the claimed invention accomplishes any technical improvement or solution. Thus, for these additional reasons, the abstract idea identified above in Independent Claims 1, 9 and 17 (and their respective Dependent Claims) is not integrated into a practical application under the 2019 PEG. Accordingly, Independent Claims 1, 9 and 17 (and their respective Dependent Claims) are each directed to an abstract idea under 2019 PEG. Step 2B – None of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 include additional elements that are sufficient to amount to significantly more than the abstract idea for at least the following reasons. These claims require the additional elements of: “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” as recited in Independent Claims 1, 9 and 17 (and their respective Dependent Claims). The additional elements of the “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” in Independent Claims 1, 9 and 17 (and their respective Dependent Claims), as discussed with respect to Step 2A Prong Two, amounts to no more than mere instructions to apply the exception using generic computer and hardware components. The same analysis applies here in 2B, i.e., mere instructions to apply an exception using a generic computer component cannot integrate a judicial exception into a practical application at Step 2A or provide an inventive concept in Step 2B. The above-identified additional elements are generically claimed computer components which enable the above-identified abstract idea(s) to be conducted by performing the basic functions of automating mental tasks. The courts have recognized such computer functions as well understood, routine, and conventional functions when claimed in a merely generic manner (e.g., at a high level of generality) or as insignificant extra-solution activity. See, Versata Dev. Group, Inc. v. SAP Am., Inc. , 793 F.3d 1306, 1334, 115 USPQ2d 1681, 1701 (Fed. Cir. 2015); and OIP Techs., 788 F.3d at 1363, 115 USPQ2d at 1092-93. Per Applicant’s specification, the “cochlear implant” is described generically in [0018] “this information can be used to provide patients with a better clinical experience including design, selection and/or specification of the cochlear implant as well as adjustment of the cochlear implant (which can be manual and/or automated),” and [0044] – [0045] “patients receive a cochlear implant with default settings”, “outputs of the disclosed embodiments can be used as feedback to the cochlear implant to dynamically “tune” it. A generic cochlear implant is shown drawn in Fig 1 as “an example of a cochlear implant.” Per Applicant’s specification, the “memory” is described generically in [0086] as random access memory (RAM) module 1722, a read-only memory (ROM) module 1723, a storage 1724, a database 1725” and “All of the hardware components listed above may not be necessary to practice the methods described herein”. Storage is also generically described in [0088] – [0090]. The “memory” is shown as generic box element “RAM 1722”, “ROM 1723”, or “storage 1724” in Figure 17. Per Applicant’s specification, the “processor” is described generically in [0087] as “Processor 1721 may include one or more processors”, and [0086] “an exemplary computer”. The processor is presented as generic box element “processor 1721” in Figure 17. Per Applicant’s specification, the “non-transitory computer readable medium” is described generically in [0085] “…the respective functions can be performed by software, hardware, or a combination of software and hardware,” and [0089] “one or more magnetic and/or optical disk devices, such as hard drives, CD-ROMs, DVD-ROMs, or any other type of mass media device.” The “non-transitory medium” is potentially shown as generic box element “storage 1724” in Figure 17. Accordingly, in light of Applicant’s specification, the claimed terms “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium” are reasonably construed as a generic computing and hardware devices. Like SAP America vs Investpic, LLC (Federal Circuit 2018), it is clear, from the claims themselves and the specification, that these limitations require no improved computer resources, just already available computers, with their already available basic functions, to use as tools in executing the claimed process. Furthermore, Applicant’s specification does not describe any special programming or algorithms required for the “cochlear implant”, “memory”, “processor”, and “non-transitory computer readable medium”. This lack of disclosure is acceptable under 35 U.S.C. §112(a) since this hardware performs non-specialized functions known by those of ordinary skill in the computer arts. By omitting any specialized programming or algorithms, Applicant's specification essentially admits that this hardware is conventional and performs well understood, routine and conventional activities in the computer industry or arts. In other words, Applicant’s specification demonstrates the well-understood, routine, conventional nature of the above-identified additional elements because it describes these additional elements in a manner that indicates that the additional elements are sufficiently well-known that the specification does not need to describe the particulars of such additional elements to satisfy 35 U.S.C. § 112(a) (see Berkheimer memo from April 19, 2018, (III)(A)(1) on page 3). Adding hardware that performs “‘well understood, routine, conventional activit[ies]’ previously known to the industry” will not make claims patent-eligible (TLI Communications). The recitation of the above-identified additional limitations in Independent Claims 1, 9 and 17 (and their respective Dependent Claims) amounts to mere instructions to implement the abstract idea on a computer. Simply using a computer or other machinery in its ordinary capacity for economic or other tasks (e.g., to receive, store, or transmit data) or simply adding a general-purpose computer or computer components after the fact to an abstract idea (e.g., a fundamental economic practice or mathematical equation) does not provide significantly more. See Affinity Labs v. DirecTV, 838 F.3d 1253, 1262, 120 USPQ2d 1201, 1207 (Fed. Cir. 2016) (cellular telephone); and TLI Communications LLC v. AV Auto, LLC, 823 F.3d 607, 613, 118 USPQ2d 1744, 1748 (Fed. Cir. 2016) (computer server and telephone unit). Moreover, implementing an abstract idea on a generic computer, does not add significantly more, similar to how the recitation of the computer in the claim in Alice amounted to mere instructions to apply the abstract idea of intermediated settlement on a generic computer. A claim that purports to improve computer capabilities or to improve an existing technology may provide significantly more. McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1314-15, 120 USPQ2d 1091, 1101-02 (Fed. Cir. 2016); and Enfish, LLC v. Microsoft Corp., 822 F.3d 1327, 1335-36, 118 USPQ2d 1684, 1688-89 (Fed. Cir. 2016). However, a technical explanation as to how to implement the invention should be present in the specification for any assertion that the invention improves upon conventional functioning of a computer, or upon conventional technology or technological processes. That is, the disclosure must provide sufficient details such that one of ordinary skill in the art would recognize the claimed invention as providing an improvement. Here, Applicant’s specification does not include any discussion of how the claimed invention provides a technical improvement realized by these claims over the prior art or any explanation of a technical problem having an unconventional technical solution that is expressed in these claims. Instead, as in Affinity Labs of Tex. v. DirecTV, LLC 838 F.3d 1253, 1263-64, 120 USPQ2d 1201, 1207-08 (Fed. Cir. 2016), the specification fails to provide sufficient details regarding the manner in which the claimed invention accomplishes any technical improvement or solution. For at least the above reasons, the apparatus and methods of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 are directed to applying an abstract idea as identified above on a general-purpose computer without (i) improving the performance of the computer itself, or (ii) providing a technical solution to a problem in a technical field. None of Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 provides meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that these claims amount to significantly more than the abstract idea itself. Taking the additional elements individually and in combination, the additional elements do not provide significantly more. Specifically, when viewed individually, the above-identified additional elements for Step 2A Prong 2 in Independent Claims 1, 9 and 17 (and their respective Dependent Claims) do not add significantly more because they are simply an attempt to limit the abstract idea to a particular technological environment. That is, neither the general computer elements nor any other additional element adds meaningful limitations to the abstract idea because these additional elements represent insignificant extra-solution activity. When viewed as a combination, these above-identified additional elements simply instruct the practitioner to implement the claimed functions with well-understood, routine and conventional activity specified at a high level of generality in a particular technological environment. As such, there is no inventive concept sufficient to transform the claimed subject matter into a patent-eligible application. When viewed as whole, the above-identified additional elements do not provide meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that the claims amount to significantly more than the abstract idea itself. Thus, Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 merely apply an abstract idea to a computer and do not (i) improve the performance of the computer itself (as in Bascom and Enfish), or (ii) provide a technical solution to a problem in a technical field (as in DDR). Therefore, none of the Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 amounts to significantly more than the abstract idea itself. Accordingly, Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23 are not patent eligible and rejected under 35 U.S.C. 101. Response to Arguments Applicant's arguments filed 25 JUNE 2026 have been fully considered but they are not persuasive. Regarding the 35. U.S.C. 101 Analysis: Applicant argues at [Page 22, “Claim Rejections 35 USC 101” Section] – [Page 23, 2nd Full Paragraph] that the addition of “the eCAP determines an estimated number of surviving neurons in a cochlear nerve of a patient, and the cochlear implant of the patient is adjusted using the estimated number of surviving neurons in the cochlear nerve” transforms the abstract idea into a patent eligible application of the abstract idea such that these claims amount to significantly more than the abstract idea itself. As noted in the currently-maintained 35 U.S.C. 101 rejection above, adjusting the cochlear implant would not be considered a mental process, with the interpretation that the adjustment is an automatic adjustment of the electrodes of the cochlear implant itself per Applicant’s Specification at [0044] of “deactivating electrodes of the cochlear implant near nerves that do not function properly and/or passing more stimulation/information through regions with the best functioning nerves. D. Repeat a – c for each electrode in the cochlear implant; resulting in e. Optimized setting of the cochlear implant that help the patient hear better” and [0018]. However, given the adjusted limitation is under the conditionality of “if”, the claim does not necessarily require any adjustment of the cochlear implant and can just require the remaining abstract elements, which would be a mental process without significantly more. Without the “adjusted” limitation of the claim necessarily included, the remainder of the claim does not transform the abstract idea into a patent eligible application of the abstract idea such that these claims amount to significantly more than the abstract idea itself. A suggested amendment to the term could be “determining that the neural response waveform comprises the eCAP, then the eCAP determines…and the cochlear implant of the patient is adjusted using the estimated number of surviving neurons in the cochlear nerve” to ensure that the condition is positively recited. The argument is not persuasive. Conclusion In light of the current 112(b) rejections and related drawing objections, no prior art rejection is currently able to be applied to Claims 1, 3 – 7, 9, 11 - 15, 17, and 19 – 23. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MELISSA J MONTGOMERY whose telephone number is (571)272-2305. The examiner can normally be reached Monday - Friday 7:30 - 5:00 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at (571) 272 - 4233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MELISSA JO MONTGOMERY/Examiner, Art Unit 3791 /JUSTIN XU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Nov 22, 2022
Application Filed
Nov 22, 2022
Response after Non-Final Action
Sep 23, 2025
Non-Final Rejection mailed — §101, §112
Dec 23, 2025
Response Filed
Feb 05, 2026
Final Rejection mailed — §101, §112
Jun 25, 2026
Request for Continued Examination
Jul 01, 2026
Response after Non-Final Action
Nov 03, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778380
IMAGE PROCESSING DEVICE, ENDOSCOPE SYSTEM, AND METHOD OF OPERATING IMAGE PROCESSING DEVICE
4y 7m to grant Granted Nov 03, 2026
Patent 12714325
SYSTEMS FOR AND METHODS OF PERFORMING GASTROINTESTINAL MANOMETRY
3y 3m to grant Granted Aug 25, 2026
Patent 12605121
APPARATUS AND METHOD FOR ESTIMATING BIO-INFORMATION
4y 2m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 3 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
15%
Grant Probability
55%
With Interview (+40.0%)
3y 4m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 27 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month